Drug-coated angioplasty balloons could address DES (drug-eluting stent) safety concerns
This article was originally published in Clinica
Executive Summary
Putting a drug coating on an angioplasty balloon is holding out promise as an alternative way of preventing restenosis - the renarrowing of the coronary arteries - after the procedure. Evidence presented at the annual Transcatheter Cardiovascular Therapeutics (TCT) symposium in Washington this week has led its researchers to predict that the technology could eventually replace stents altogether.